Meeder Advisory Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Meeder Advisory Services's CRL Position: Q2 2026 in Review
Meeder Advisory Services reduced its Charles River Laboratories (CRL) stake by 2.7% in Q2 2026, selling an estimated $7.12K and leaving 1,417 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #532.
Meeder Advisory Services first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Meeder Advisory Services held 1,417 shares of Charles River Laboratories worth $321K as of Q2 2026.
- Meeder Advisory Services sold 40 Charles River Laboratories shares in Q2 2026, an estimated $7.12K.
- Charles River Laboratories made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #532 holding.
- Meeder Advisory Services first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.